JP2023528255A5 - - Google Patents

Info

Publication number
JP2023528255A5
JP2023528255A5 JP2022570271A JP2022570271A JP2023528255A5 JP 2023528255 A5 JP2023528255 A5 JP 2023528255A5 JP 2022570271 A JP2022570271 A JP 2022570271A JP 2022570271 A JP2022570271 A JP 2022570271A JP 2023528255 A5 JP2023528255 A5 JP 2023528255A5
Authority
JP
Japan
Application number
JP2022570271A
Other languages
Japanese (ja)
Other versions
JP7785696B2 (ja
JP2023528255A (ja
JPWO2021236548A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/032818 external-priority patent/WO2021236548A1/en
Publication of JP2023528255A publication Critical patent/JP2023528255A/ja
Publication of JP2023528255A5 publication Critical patent/JP2023528255A5/ja
Publication of JPWO2021236548A5 publication Critical patent/JPWO2021236548A5/ja
Application granted granted Critical
Publication of JP7785696B2 publication Critical patent/JP7785696B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022570271A 2020-05-18 2021-05-17 操作されたt細胞受容体および使用の方法 Active JP7785696B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063026445P 2020-05-18 2020-05-18
US63/026,445 2020-05-18
PCT/US2021/032818 WO2021236548A1 (en) 2020-05-18 2021-05-17 Engineered t cell receptors and methods of use

Publications (4)

Publication Number Publication Date
JP2023528255A JP2023528255A (ja) 2023-07-04
JP2023528255A5 true JP2023528255A5 (https=) 2024-05-28
JPWO2021236548A5 JPWO2021236548A5 (https=) 2024-05-28
JP7785696B2 JP7785696B2 (ja) 2025-12-15

Family

ID=78708026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022570271A Active JP7785696B2 (ja) 2020-05-18 2021-05-17 操作されたt細胞受容体および使用の方法

Country Status (8)

Country Link
US (1) US20230190812A1 (https=)
EP (1) EP4153618A4 (https=)
JP (1) JP7785696B2 (https=)
CN (1) CN116322715A (https=)
AU (1) AU2021276264A1 (https=)
CA (1) CA3183663A1 (https=)
TW (1) TWI907427B (https=)
WO (1) WO2021236548A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3236237A1 (en) * 2021-10-25 2023-05-04 Board Of Regents, The University Of Texas System Peptides and engineered t cell receptors targeting mage-a4 antigen and methods of use
CN114149978B (zh) * 2022-02-09 2022-04-26 深圳博雅感知药业有限公司 制备car-t细胞的方法
CN116836261A (zh) * 2022-03-24 2023-10-03 香雪生命科学技术(广东)有限公司 一种识别mage-a4抗原的高亲和力tcr及其序列和应用
JP2026505826A (ja) 2023-02-03 2026-02-18 ゼルナ・イミュノセラピー・アーエス 抗mage-a4 t細胞受容体
CN120924527B (zh) * 2025-10-16 2026-02-06 内蒙古科为博生物科技有限公司 一种内切葡聚糖酶突变体eg06、其编码基因及其产品与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3173480A3 (en) * 2007-03-05 2017-08-16 International Institute of Cancer Immunology, Inc. Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
CN102272153B (zh) * 2008-11-24 2015-04-15 德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 高亲和力t细胞受体及其应用
GB0911566D0 (en) * 2009-07-03 2009-08-12 Immunocore Ltd T cell receptors
KR20140039318A (ko) * 2011-06-28 2014-04-01 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 펩티드 암 항원 특이적 t 세포의 리셉터 유전자
CN106103711A (zh) * 2013-11-21 2016-11-09 组库创世纪株式会社 T细胞受体和b细胞受体库分析系统及其在治疗和诊断中的应用
US11047011B2 (en) * 2015-09-29 2021-06-29 iRepertoire, Inc. Immunorepertoire normality assessment method and its use
PL3440105T3 (pl) * 2016-04-08 2022-08-29 Immunocore Limited Receptory komórek t
AU2018318303A1 (en) * 2017-08-18 2020-04-09 Gritstone Bio, Inc. Antigen-binding proteins targeting shared antigens
US20210061914A1 (en) * 2017-12-28 2021-03-04 Gritstone Oncology, Inc. Antigen-Binding Proteins Targeting Shared Antigens
EP3731861A1 (en) * 2017-12-29 2020-11-04 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft T cell receptors for tumor specific proteasome splice variants and uses thereof
EP3749753B1 (en) * 2018-02-09 2025-04-02 Immatics US, Inc. Methods for manufacturing t cells
DE102018108612A1 (de) * 2018-03-21 2019-09-26 Immatics US, Inc. Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
EP3962939A4 (en) * 2019-05-03 2023-05-17 Gigamune, Inc. MODIFIED CELLS EXPRESSING ANTITUMOR T-LYMPHOCYTE RECEPTORS AND METHODS OF USING THEM

Similar Documents

Publication Publication Date Title
JP2023528255A5 (https=)
BR202021009493U2 (https=)
CN305552639S (https=)
CN305556907S (https=)
CN305559038S (https=)
CN305680354S (https=)
CN305679726S (https=)
CN305678282S (https=)
CN305589130S (https=)
CN305536773S (https=)
CN305536749S (https=)
CN305536339S (https=)
CN305535970S (https=)
CN305535679S (https=)
CN305535510S (https=)
CN305588018S (https=)
CN305535125S (https=)
CN305534935S (https=)
CN305534765S (https=)
CN305534282S (https=)
CN305533403S (https=)
CN305533376S (https=)
CN305532681S (https=)
CN305532029S (https=)
CN305530700S (https=)